Of the 6877 skin test records in the database, 534 patients were identified who had at least a moderate SPT to short ragweed (approximately an 8mm wheal or greater), had a diagnosis of allergic rhinitis, were not already on SCIT, had a current email address on file and, based on the prescribing information of the recently approved sublingual ragweed extract tablet, were between the ages of 18 and 65.